Global Markets Outlook: Maintain Defensive Posture
Our outlook for global equity markets remains cautious and we expect additional weakness and consolidation, notwithstanding shorter-term...
684 Views
Global Equity Strategy: Market Deterioration Continues; Cyclical & Growth Sectors Breaking Down
In our October International Strategy, we provide a synopsis on current market conditions around the globe, and explore the following themes in...
507 Views
Flat Topline, Unfavourable Product Mix Results in Gross Margin Decline over Next 3-5 Years
We reiterate our āEqual-weightā rating on the stock after reviewing our model post FY17 (YE Mar-18) earnings.Kissei Pharmaceutical Co Ltd (4547...
358 Views
Kissei FY17 Earnings - First Glance
Kissei Pharmaceutical Co Ltd (4547 JP) reported FY17 results on May 09, 2018 Urief and P-Tol driven FY17 top-line growth in line with...
98 Views
Opdivo Singled Out in Government Rule Change
The suggestion of government orchestration against Onoās immunotherapy treatment Opdivo (nivolumab) has moved a stage further with a report in the...
5.8k Views